Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - TOTAL CURRENT ASSETS
Total Current Assets INBX - Inhibrx Biosciences, Inc.
295 M
LAST VALUE
45.71%
2 YEAR CAGR
120.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR